Last updated October 21, 2026

DermaSetuAI

Developing AI software to help clinicians assess and triage skin lesions

DermatologyClinical Decision SupportProvider Workflow

Long waits for dermatology assessment can delay diagnosis and treatment of suspicious skin lesions. Clinicians need to distinguish a wide range of skin conditions, while uneven skin-tone representation in AI training data can make assessment less reliable for patients with darker skin.

DermaSetuAI is developing AI software to help NHS clinicians triage skin lesions from dermoscopic images. Its prototype combines image analysis with clinical parameters to provide ranked diagnoses and plain-language explanations for clinician review.

Investor Signals

What stands out about DermaSetuAI

Interested in More Startups Like DermaSetuAI?

Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.

Get Deal Flow

Get the DealBio Pulse

Weekly insights on health and longevity startups, standout founders, key markets, and notable exits.

You can unsubscribe at any time.